Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.The company, whose profit topped expectations for the fourth straight quarter, cut its 2014 earnings forecast to $4.86-$4.89 per share to exclude gains from its vaccine business that it sold to Pfizer Inc about three months ago.Baxter had earlier expected to earn $5.10-$5.20 per share, before special items.The discontinued vaccines franchise business earned 4 cents per share, excluding items, for the third quarter ended Sept. 30.
Baxter International Inc. (Baxter) is a global, diversified healthcare company. Shares of BAX fell by 0.76% or $-0.52/share to $68.34. In the past year, the shares have traded as low as $64.78 and as high as $77.31. On average, 2234610 shares of BAX exchange hands on a given day and today's volume is recorded at 4599769.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 0.95% or $-0.27/share to $28.19. In the past year, the shares have traded as low as $27.56 and as high as $32.96. On average, 24140400 shares of PFE exchange hands on a given day and today's volume is recorded at 41192192.
Source
